Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Aditxt, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 15 | 14 | −1 |
| Shares | 679.2K | 699.0K | +19.7K (+2.9%) |
| Value | $618.3K | $313.8K | −$304.5K (−49.2%) |
New holders (2)
Institutions that held Aditxt, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 46,465 | $20.9K | 0.00% |
| JPMorgan Chase & Co | 2,106 | $948 | 0.00% |
Sold out (3)
Institutions that held Aditxt, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Bank of New York Mellon Corp | 183,612 | $167.4K |
| HRT Financial LP | 11,815 | $10.0K |
| Two Sigma Securities, LLC | 10,873 | $9.91K |